Physician profile
Mark Magnus
NPI 1710340724
$4,843.52
in general payments reported to CMS, 2019-2025
15 companies · $1,499 in 2025
The $1,499 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,237 · 2020: $1,077 · 2021: $79.72 · 2022: $194 · 2023: $262 · 2024: $495 · 2025: $1,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363 · Travel and Lodging: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.77 |
| Travel and Lodging | $893.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,165.27 | 2019-2025 | Flexband, Citrefix, Flexband Plus |
| Foundation Medical, LLC | $693.32 | 2025 | |
| Arthrex, INC. | $462.45 | 2025 | |
| Medical Device Business Services, INC. | $314.98 | 2019 | |
| Medline Industries LP | $298.84 | 2019 | |
| Organogenesis INC. | $222.74 | 2021-2023 | Puraply |
| Integra Lifesciences Corporation | $185.82 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Pharmaceuticals, INC | $122.81 | 2019 | |
| Horizon Therapeutics Plc | $122.66 | 2019 | |
| Smith+Nephew, INC. | $110.80 | 2019 | |
| Acera Surgical, INC. | $55.72 | 2021 | |
| Enduromed, LLC | $24.55 | 2023 | |
| Abbott Laboratories | $24.34 | 2023 | Proclaim |
| Treace Medical Concepts, INC. | $23.68 | 2025 | |
| Solventum Corporation | $15.54 | 2024 | Prevena, Activ.A.C., V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Magnus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.